A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/1745-6215-16-9

PubMed Identifier: 25563714

Publication URI: http://europepmc.org/abstract/MED/25563714

Type: Journal Article/Review

Volume: 16

Parent Publication: Trials

ISSN: 1745-6215